Synthesis of some new 4-styryltetrazolo[1,5-a]quinoxaline and 1-substituted-4-styryl[1,2,4]triazolo[4,3-a]quinoxaline derivatives as potent anticonvulsants

dc.contributor.authorWagle, S.
dc.contributor.authorVasudeva Adhikari, A.V.
dc.contributor.authorSuchetha Kumari, N.S.
dc.date.accessioned2026-02-05T09:36:43Z
dc.date.issued2009
dc.description.abstract4-Methyltetrazolo[1,5-a]quinoxaline (3) was prepared by the azide cyclocondensation of 2-chloro-3-methylquinoxaline (2). The reaction of 3 with aromatic aldehydes furnished 4-styryltetrazolo[1,5-a]quinoxalines (4a-f). Compound 2, on treatment with hydrazine hydrate gave 2-hydrazino-3-methylquinoxaline (5). The ring closure of 5 was achieved by the reaction of orthoesters and trifluoroacetic acid to yield 4-methyl-1-(substituted)[1,2,4]triazolo[4,3-a]quinoxalines (7a-c). Further, reaction of 7a-c with different aromatic aldehydes furnished the title compounds, 4-styryl-1-(substituted)[1,2,4]triazolo[4,3-a]quinoxalines (8a-i) in good yield. In another scheme, the hydrazino compound 5 was treated with different aromatic aldehydes to yield corresponding N-arylidenehydrazino quinoxalines (6a-d). Further, the oxidative cyclization of hydrazones by nitrobenzene yielded 1-aryl-4-methyl[1,2,4]triazolo[4,3-a]quinoxalines (7d-g), which on condensation with aromatic aldehydes gave the title compounds, 1-aryl-4-styryl[1,2,4]triazolo[4,3-a]quinoxalines (8j-u). The newly synthesized compounds have been characterized by FTIR, 1H NMR, 13C NMR and mass spectral data, followed by elemental analysis. Some of the compounds were screened for in vivo anticonvulsant activity. Few of them exhibited promising results. © 2008 Elsevier Masson SAS. All rights reserved.
dc.identifier.citationEuropean Journal of Medicinal Chemistry, 2009, 44, 3, pp. 1135-1143
dc.identifier.issn2235234
dc.identifier.urihttps://doi.org/10.1016/j.ejmech.2008.06.006
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/27656
dc.subject1,4 dimethyl[1,2,4]triazolo[4,3 a]quinoxaline
dc.subject2 chloro 3 methylquinoxaline
dc.subject2 hydrazino 3 methylquinoxaline
dc.subject4 methyl 1 (trifluoromethyl)[1,2,4]triazolo[4,3 a]quinoxaline
dc.subject4 methyl [1,2,4]triazolo[4,3 a]quinoxaline derivative
dc.subject4 methyl[1,2,4]triazolo[4,3 a]quinoxaline derivative
dc.subject4 methyltetrazolo[1,5 a]quinoxaline
dc.subject4 styryl[1,2,4]triazolo[4,3 a]quinoxaline derivative
dc.subject4 styryltetrazolo[1,5 a]quinoxaline derivative
dc.subject[1,2,4]triazolo[4,3 a]quinoxaline derivative
dc.subjectdiazepam
dc.subjectquinoxaline derivative
dc.subjectunclassified drug
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanticonvulsant activity
dc.subjectarticle
dc.subjectcarbon nuclear magnetic resonance
dc.subjectchemical reaction
dc.subjectcontrolled study
dc.subjectdose response
dc.subjectdrug potency
dc.subjectdrug structure
dc.subjectdrug synthesis
dc.subjectin vivo study
dc.subjectinfrared spectroscopy
dc.subjectmale
dc.subjectmouse
dc.subjectnonhuman
dc.subjectproton nuclear magnetic resonance
dc.subjectseizure
dc.subjectsubstitution reaction
dc.subjectAnimals
dc.subjectAnticonvulsants
dc.subjectMagnetic Resonance Spectroscopy
dc.subjectMale
dc.subjectMice
dc.subjectQuinoxalines
dc.subjectSpectroscopy, Fourier Transform Infrared
dc.titleSynthesis of some new 4-styryltetrazolo[1,5-a]quinoxaline and 1-substituted-4-styryl[1,2,4]triazolo[4,3-a]quinoxaline derivatives as potent anticonvulsants

Files

Collections